课题基金 / 基金详情

DOSE RANGING STUDY TO DETERMINE THE EFFECT OF A 20,000 EU DOSE OF INHALED CCRE

DOSE RANGING STUDY TO DETERMINE THE EFFECT OF A 20,000 EU DOSE OF INHALED CCRE
确定 20,000 EU 剂量吸入 CCRE 效果的剂量范围研究
批准号:
7625538
负责人:
David B. Peden
金额:
$0.04万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

David B. Peden的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this phase I research study is to identify a dose of inhaled endotoxin that does not cause prolonged cough, shortness of breath or other problems, but causes changes in sputum cell samples that can be measured.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Training in Allergy and Clinical Immunology
Research Training in Allergy and Clinical Immunology
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: